- Senate passes Drug Quality and Security Act
- Missouri voters oppose prescription-only restrictions on PSE
- Calif. senator introduces prescription drug abuse bill
- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
SACRAMENTO, Calif. — The California State Senate Health Committee on Wednesday tabled a bill that would require a prescription for the purchase of a pseudoephedrine product, exempting children's liquid formulations.
The bill initially failed to pass the committee by a vote of 2-2 with five no-votes. Subsequently, the committee placed the bill up for reconsideration by a vote of 7-0 with two no-votes. No subsequent hearing date has been posted the Senate's website.
The National Association of Chain Drug Stores reaffirmed its opposition to this piece of legislation in a statement released Friday. “Requiring a prescription for over-the-counter products containing pseudoephedrine would be a cure worse than the disease,” said NACDS president and CEO Steve Anderson. “A prescription requirement would disempower patients in their own health care and would only increase healthcare costs.”